Cargando…
Large-scale mGluR5 network abnormalities linked to epilepsy duration in focal cortical dysplasia
To determine the extent of metabotropic glutamate receptor type 5 (mGluR5) network abnormalities associated with focal cortical dysplasia (FCD), we performed graph theoretical analysis of [(11)C]ABP688 PET binding potentials (BP(ND)), which allows for quantification of mGluR5 availability. Undirecte...
Autores principales: | DuBois, Jonathan M., Mathotaarachchi, Sulantha, Rousset, Olivier G., Sziklas, Viviane, Sepulcre, Jorge, Guiot, Marie-Christine, Hall, Jeffery A., Massarweh, Gassan, Soucy, Jean-Paul, Rosa-Neto, Pedro, Kobayashi, Eliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787952/ https://www.ncbi.nlm.nih.gov/pubmed/33401137 http://dx.doi.org/10.1016/j.nicl.2020.102552 |
Ejemplares similares
-
Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [(11)C]ABP688 Positron-Emission Tomography (PET) Imaging
por: DuBois, Jonathan M., et al.
Publicado: (2016) -
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2018) -
Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain
por: Ng, Kok Pin, et al.
Publicado: (2017) -
Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [(18)F]THK5351 uptake in progressive supranuclear palsy
por: Ng, Kok Pin, et al.
Publicado: (2019) -
Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study
por: Zimmermann, Maria, et al.
Publicado: (2022)